A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. - Wikidata - awgldk - TriplyDB

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

http://www.wikidata.org/entity/Q33996270

about

Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Genomic profiling in luminal breast cancer Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement Future directions for the early detection of recurrent breast cancer Signatures of breast cancer metastasis at a glance Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.Clinical utility of gene expression profiling data for clinical decision-making regarding adjuvant therapy in early stage, node-negative breast cancer: a case report.Postoperative fever: the potential relationship with prognosis in node negative breast cancer patients Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer Factors influencing the statistical power of complex data analysis protocols for molecular signature development from microarray data Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer.Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.Unraveling human complexity and disease with systems biology and personalized medicine.Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.Tumor gene expression profiling in women with breast cancer. Test category: prognostic.Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.Automated quantification of aligned collagen for human breast carcinoma prognosis.Gene expression in fixed tissues and outcome in hepatocellular carcinoma.Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?Should Histologic Grade Be Incorporated into the TNM Classification System for Small (T1, T2) Node-Negative Breast Adenocarcinomas?Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation.Genome-based risk prediction for early stage breast cancer.Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.

P2860

Q21089802-3EA9CF82-DD04-4A51-AA72-92AD11D7D734 Q24597456-5DE5094F-15C7-447E-AF53-068C0B49D7E9 Q26778675-013B9D3D-E481-4394-AF32-349427204B00 Q26830362-BC425410-7B53-4FAA-9672-2AF597464F31 Q26862681-FBCF0EC5-73EE-4EF6-A58B-9D4437F7E6D7 Q27020973-515AA8E1-9B40-43C7-A04B-A738D96E20D9 Q27022040-24B3A4F4-45F9-429A-BF9F-9BF091936C0A Q28071451-6D02C4FE-D092-468D-9830-15DB719B3BCC Q28077637-15D42AF0-E540-4BAE-B0BC-97AB7FA8312E Q28277288-FEB8E335-15A4-483C-94DD-1253C6BE32B6 Q28727086-547EA05D-4C33-4009-85A9-406267684F3F Q30245184-2A3882EE-82DD-4652-A3F5-3BFEB532BF40 Q30419845-9BFE45E8-5344-4DA7-913F-A52FE4628279 Q30440216-D6AE87E3-E119-4465-A561-4610365C6784 Q30882876-24D817F8-34C6-4A9C-9182-4A45C379B46A Q30994909-BB163591-A6E6-44DA-B9CD-B5C1AC15D330 Q31101528-63F62B65-50D5-4B98-829F-6C00213CA98A Q31152670-DFE111D5-EE9B-456C-8B66-A4D132966676 Q33418596-EE123329-AF33-4A25-A631-A0CD793CDD19 Q33472698-B6F7B665-846B-4093-8FC9-B917FA0B116B Q33484404-03462793-3472-4812-86D8-C241567911AA Q33560459-8191564F-D74E-474F-96B7-6ADB97C5EFE9 Q33573884-41D1FE84-A1DD-4489-A20C-9CB612C892E4 Q33698446-9229BDFE-832F-4C38-8D10-5A28F9F12680 Q33736582-94282B68-090F-423F-86B0-453C2FF6A6FE Q33766513-87228950-5F3E-4E1E-BB7E-F28493285F86 Q33770332-62A64B2A-F625-4747-8F53-9A7F19EFA9C8 Q33915023-7B953298-A933-4B76-BCD1-3008D0615ECB Q33922958-2440209C-6AAA-4FF8-B85A-004ACBCDF195 Q34048120-F396CDA3-AC9C-4AE7-8AE5-0ABCB2AABB34 Q34130881-8E9DB6A0-09FB-4980-BB8F-7AEB9C61F7EF Q34171119-2E45B7EF-BFCE-408C-848B-24FDC29F8795 Q34210986-BFA1DBD2-ACCB-4127-BFA5-C904ED606AD5 Q34235518-5DBCA6A0-E3A0-4813-9512-510A4A811DC5 Q34338152-0311B7C4-31A8-415E-BEDA-CAC473ABAD3E Q34340071-E769DA17-6168-478B-8BEA-2401664DD456 Q34341066-5FBDB6CF-26FD-45EA-89CE-2E242F72DDE8 Q34359289-0FBBAB69-6B5E-4907-8794-1FFE26078EB3 Q34703634-E985D2A9-932F-443F-A566-8EDEEC58D47F Q35042433-94B94532-E4EB-45E8-BF5C-3E7B34F3F5D9

P2860

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

http://www.wikidata.org/entity/Q33996270

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

A population-based study of tu ...... lymph node-negative patients.

@ast

A population-based study of tu ...... lymph node-negative patients.

@en

type

label

A population-based study of tu ...... lymph node-negative patients.

@ast

A population-based study of tu ...... lymph node-negative patients.

@en

prefLabel

A population-based study of tu ...... lymph node-negative patients.

@ast

A population-based study of tu ...... lymph node-negative patients.

@en

P1433

Q33996270-F1087A35-FCE1-4F23-93EE-BA006F14101C

P1476

Q33996270-F17DA60C-3482-4C50-AD72-CDA2E6940F97

P2093

Q33996270-0A9F0A5C-1DE9-40E0-8C9B-33DD60966196

Q33996270-15380379-0938-4267-B1D0-D66EA0DCABA5

Q33996270-2D631335-0F98-4630-9286-35A3B8F4993E

Q33996270-458E1F42-71D7-4AE7-A50A-425B9A73E981

Q33996270-50AF6416-B684-44C1-AA06-FF100F0EA203

Q33996270-54869089-BFDD-4BBA-B1F9-DCFECD269380

Q33996270-699B3F8A-39EF-4750-864D-77452229B884

Q33996270-7B426BA6-9C8F-4938-954C-0FBD40E4BC1D

Q33996270-81A05597-DD76-444D-BCF2-F96DA1A90BEF

Q33996270-946BE749-DE75-4459-9481-EA42062C1D14

P2860

Q33996270-084E9F5F-118E-4254-BF09-7899E66EE061

Q33996270-09BA56D0-9A06-4DA0-94B2-2096AAB90F22

Q33996270-293C9C9A-697E-4ACF-B556-EE3E0A07719C

Q33996270-2AC18BBF-3BC1-4691-8B16-E9317CA0EF50

Q33996270-2F6D8961-C582-463E-B0ED-5E982C678828

Q33996270-3A71A1BA-35FB-4A38-A16A-761171B571AB

Q33996270-4589B80A-564D-4E24-A071-24A75292663A

Q33996270-4CF72C8B-BEF6-482A-9D27-D83A0487BC5E

Q33996270-4EFCA4C5-3738-4E3A-A938-53C9B683B111

Q33996270-50FF1DC9-AA44-4882-B1F0-18BC889D2CBE

P2888

Q33996270-990BE2E6-CA22-41F6-BFE7-13904F4AFF28

P304

Q33996270-0BDD2B65-7970-4706-9570-D95B1FCB52A0

P31

Q33996270-A7040943-1E84-444C-9E3D-C83B480757E7

P356

Q33996270-04A11FC8-29B4-4771-9CB4-EFB2C1A910AB

P433

Q33996270-51575577-A754-43FA-9B5E-768F8C1E7534

P478

Q33996270-583DA3C3-8C09-423D-AE11-554BF0AD1709

P577

Q33996270-A94636B4-2101-4AD2-8EFC-AE2EF7E1D265

P5875

Q33996270-DF642E60-7D5A-4E82-B920-2EDADCC11FD8

P6179

Q33996270-0AF6E704-542C-45AC-8FB7-3B211F513C5A

P698

Q33996270-4EA61FDE-6D8C-4B86-9787-68B4A1406D83

P921

Q33996270-34EF3560-4F55-4316-A76C-6B0BAFAD2ACD

P932

Q33996270-C2771B55-3B87-4E68-B925-BB44B17E9626

P356

P1433

Breast Cancer Research

P1476

A population-based study of tu ...... lymph node-negative patients.

@en

P2093

Angela Capra

http://www.w3.org/2001/XMLSchema#string

Bryan Langholz

http://www.w3.org/2001/XMLSchema#string

Charles P Quesenberry

http://www.w3.org/2001/XMLSchema#string

Claire Alexander

http://www.w3.org/2001/XMLSchema#string

Deborah Greenberg

http://www.w3.org/2001/XMLSchema#string

Drew Watson

http://www.w3.org/2001/XMLSchema#string

James Hackett

http://www.w3.org/2001/XMLSchema#string

Joffre Baker

http://www.w3.org/2001/XMLSchema#string

Laurel A Habel

http://www.w3.org/2001/XMLSchema#string

Louis Fehrenbacher

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

P2888

P304

R25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1412

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7044467

http://www.w3.org/2001/XMLSchema#string

P6179

1038723589

http://www.w3.org/2001/XMLSchema#string

P698

16737553

http://www.w3.org/2001/XMLSchema#string

P921

P932

1557737

http://www.w3.org/2001/XMLSchema#string